21 – 30 of 86
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
Bortezomib Does Not Reduce Muscular Dystrophy in the dy2J/dy2J Mouse Model of Laminin α2 Chain-Deficient Muscular Dystrophy.
(
- Contribution to journal › Article
-
Mark
Update on hereditary colorectal cancer
(
- Contribution to journal › Scientific review
-
Mark
Skeletal muscle wasting and renewal : a pivotal role of myokine IL-6
(
- Contribution to journal › Scientific review
-
Mark
Congenital muscular dystrophy with laminin α2 chain-deficiency. Initiation of disease and development of treatment
2016)(
- Thesis › Doctoral thesis (compilation)
- 2015
-
Mark
Deletion of integrin α7 subunit does not aggravate the phenotype of laminin α2 chain-deficient mice.
(
- Contribution to journal › Article
-
Mark
Dystrophin deficiency reduces atherosclerotic plaque development in ApoE-null mice.
(
- Contribution to journal › Article
-
Mark
Laminin-α2 Chain-Deficient Congenital Muscular Dystrophy: Pathophysiology and Development of Treatment.
(
- Contribution to journal › Article
- 2014
-
Mark
Laminin α2 Chain-Deficiency is Associated with microRNA Deregulation in Skeletal Muscle and Plasma.
(
- Contribution to journal › Article
-
Mark
Fibrin binds to collagen and provides a bridge for alpha V beta 3 integrin-dependent contraction of collagen gels
(
- Contribution to journal › Article
-
Mark
Quantitative proteomic analysis reveals metabolic alterations, calcium dysregulation and increased expression of extracellular matrix proteins in laminin α2 chain-deficient muscle.
(
- Contribution to journal › Article